(Q34050688)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11013762%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

review article

1 reference

title

HIV-1 protease: maturation, enzyme specificity, and drug resistance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11013762%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11013762%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

J M Louis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11013762%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

I T Weber

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11013762%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J Tözsér

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11013762%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

G M Clore

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11013762%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11013762%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

published in

Advances in Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11013762%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11013762%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

111-146

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11013762%20AND%20SRC:MED&resulttype=core&format=json

Molecular basis of HIV-1 protease drug resistance: structural analysis of mutant proteases complexed with cyclic urea inhibitors

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Sequence-specific resonance assignments of the 1H-NMR spectra and structural characterization in solution of the HIV-1 transframe protein p6.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Resistance to human immunodeficiency virus type 1 protease inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Proteolytic processing mechanisms of a miniprecursor of the aspartic protease of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Characterization of human immunodeficiency virus type-1 (HIV-1) particles that express protease-reverse transcriptase fusion proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Predicting human immunodeficiency virus protease cleavage sites in proteins by a discriminant function method

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Genetic locus, primary structure, and chemical synthesis of human immunodeficiency virus protease

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

The HIV-1 protease as a therapeutic target for AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Subsite preferences of retroviral proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

A possible regulation of negative factor (Nef) activity of human immunodeficiency virus type 1 by the viral protease.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Different requirements for productive interaction between the active site of HIV-1 proteinase and substrates containing -hydrophobic*hydrophobic- or -aromatic*pro- cleavage sites

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Kinetic characterization and cross-resistance patterns of HIV-1 protease mutants selected under drug pressure

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Comparative analysis of the sequences and structures of HIV-1 and HIV-2 proteases

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Energy calculations and analysis of HIV-1 protease-inhibitor crystal structures

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Molecular characterization of gag proteins from simian immunodeficiency virus (SIVMne).

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Characterization of human immunodeficiency virus type 1 variants with increased resistance to a C2-symmetric protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Human immunodeficiency virus-1 protease. 2. Use of pH rate studies and solvent kinetic isotope effects to elucidate details of chemical mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Characterization of ribosomal frameshifting in HIV-1 gag-pol expression

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Fidelity of HIV-1 reverse transcriptase copying RNA in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Sub-site preferences of the aspartic proteinase from the human immunodeficiency virus, HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

The HIV Protease and Therapies for AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Standardized and simplified nomenclature for proteins common to all retroviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Effect of point mutations on the kinetics and the inhibition of human immunodeficiency virus type 1 protease: relationship to drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Hydrophilic Peptides Derived from the Transframe Region of Gag-Pol Inhibit the HIV-1 Protease

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Autoprocessing of the HIV-1 protease using purified wild-type and mutated fusion proteins expressed at high levels in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Substitution mutations of the highly conserved arginine 87 of HIV-1 protease result in loss of proteolytic activity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Proteolytic processing of HIV-1 protease precursor, kinetics and mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

1 reference

7 January 2021

Structural and kinetic analysis of drug resistant mutants of HIV-1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Human immunodeficiency virus. Mutations in the viral protease that confer resistance to saquinavir increase the dissociation rate constant of the protease-saquinavir complex

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Substitutions at the P2' site of gag p17-p24 affect cleavage efficiency by HIV-1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

The HIV-1 protease as enzyme and substrate: mutagenesis of autolysis sites and generation of a stable mutant with retained kinetic properties.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Ordered accumulation of mutations in HIV protease confers resistance to ritonavir

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Peptide substrates and inhibitors of the HIV-1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Retroviral proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Kinetic characterization of human immunodeficiency virus type-1 protease-resistant variants

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

A structural model for the retroviral proteases.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Hydrolysis of synthetic chromogenic substrates by HIV-1 and HIV-2 proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Intrinsic activity of precursor forms of HIV-1 proteinase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

The mechanism of action of aspartic proteases involves 'push-pull' catalysis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Substrate-dependent mechanisms in the catalysis of human immunodeficiency virus protease

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Inhibition of aspartic proteinases by synthetic peptides derived from the propart region of human prorenin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Human immunodeficiency virus, type 1 protease substrate specificity is limited by interactions between substrate amino acids bound in adjacent enzyme subsites

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Drug-resistant HIV-1 proteases identify enzyme residues important for substrate selection and catalytic rate

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

In situ processing of a retroviral nucleocapsid protein by the viral proteinase.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Three-dimensional structures of HIV-1 and SIV protease product complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

On the size of the active site in proteases. I. Papain

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Multiple Concurrent Reverse Transcriptase and Protease Mutations and Multidrug Resistance of HIV-1 Isolates from Heavily Treated Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Cross-resistance analysis of human immunodeficiency virus type 1 variants individually selected for resistance to five different protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Specificity of retroviral proteases: an analysis of viral and nonviral protein substrates

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Comparative studies on the substrate specificity of avian myeloblastosis virus proteinase and lentiviral proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Studies on the role of the S4 substrate binding site of HIV proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Kinetic and modeling studies of S3-S3' subsites of HIV proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Activity of tethered human immunodeficiency virus 1 protease containing mutations in the flap region of one subunit

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Studies on the symmetry and sequence context dependence of the HIV-1 proteinase specificity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Proteolytic cleavage of microtubule-associated proteins by retroviral proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Crystallographic analysis of human immunodeficiency virus 1 protease with an analog of the conserved CA-p2 substrate -- interactions with frequently occurring glutamic acid residue at P2' position of substrates

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

1H, 13C and 15N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest-neighbor effects

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Structure-based inhibitors of HIV-1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Inhibitors of HIV-1 protease: a major success of structure-assisted drug design

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Influence of flanking sequences on the dimer stability of human immunodeficiency virus type 1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

The gag precursor contains a specific HIV-1 protease cleavage site between the NC (P7) and P1 proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

A transient precursor of the HIV-1 protease. Isolation, characterization, and kinetics of maturation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Structural Basis for Specificity of Retroviral Proteases

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Secondary structure and signal assignments of human-immunodeficiency-virus-1 protease complexed to a novel, structure-based inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

Loss of Viral Fitness Associated with Multiple Gag and Gag-Pol Processing Defects in Human Immunodeficiency Virus Type 1 Variants Selected for Resistance to Protease Inhibitors In Vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2800%2949025-3

7 January 2021

10.1016/S1054-3589(00)49025-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11013762%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference